TABLE 1.
Mutation | No. of Patients | Age (yr) | LV Mass (g/m2) | LAV/BSA (mL/m2) | LV EF (%) | Cardiac Finding |
---|---|---|---|---|---|---|
AGPAT2 | 19 | 23±12 | 104±20 | 26±6 | 66±13 | 10 Patients with increased LV mass |
4 Patients with LV dysfunction | ||||||
1 Patient with PDA | ||||||
Seipin | 10 | 17±7 | 126±16 | 31±6 | 65±7 | 8 Patients with increased LV mass |
LMNA | 1 | 9 | 110 | 29 | 35 | Moderate LV dysfunction and dilation, no increased LV mass |
Unknown | 1 | 17 | 71 | 16 | 68 | Concentric remodeling |
AGL | 13 | 28±20 | 103±20 | 32±9 | 68±9 | 6 Patients with increased LV mass |
1 Patient with mild LV dysfunction |
Abbreviations: AGL = acquired generalized lipodystrophy, LAV/BSA = left atrial volume indexed to body surface area, PDA = patent ductus arteriosus.